Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC34H33N3O5S |
InChIKeyNYHCXQIUWIEKQC-UHFFFAOYSA-N |
CAS Registry1257235-99-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | New Zealand | 15 Jul 2024 |





